Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.22 USD | +2.36% |
|
-0.73% | +5.35% |
Oct. 24 | Earnings Flash (UHT) UNIVERSAL HEALTH REALTY INCOME TRUST Posts Q3 EPS $0.29 | MT |
Oct. 24 | Earnings Flash (UHT) UNIVERSAL HEALTH REALTY INCOME TRUST Posts Q3 Revenue $24.5M | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.54 | 3.52 | 3.51 | 3.3 | 3.38 | |||||
Return on Total Capital | 3.73 | 3.72 | 3.69 | 3.44 | 3.52 | |||||
Return On Equity % | 9.97 | 11.41 | 55.37 | 9.09 | 7.16 | |||||
Return on Common Equity | 9.97 | 11.41 | 55.37 | 9.09 | 7.16 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 94.97 | 94.81 | 94.88 | 94.45 | 94.5 | |||||
SG&A Margin | 0.61 | - | - | - | - | |||||
EBITDA Margin % | 67.4 | 66.62 | 67.4 | 63.46 | 62.15 | |||||
EBITA Margin % | 39.31 | 38.42 | 38.71 | 37.1 | 35.71 | |||||
EBIT Margin % | 34.89 | 34.76 | 35.66 | 34.7 | 33.64 | |||||
Income From Continuing Operations Margin % | 24.02 | 24.4 | 126.96 | 22.98 | 15.91 | |||||
Net Income Margin % | 24.02 | 24.4 | 126.96 | 22.98 | 15.91 | |||||
Net Avail. For Common Margin % | 24.02 | 24.4 | 126.96 | 22.98 | 15.91 | |||||
Normalized Net Income Margin | 13.47 | 15.25 | 15.88 | 14.36 | 10.09 | |||||
Levered Free Cash Flow Margin | 48.2 | 51.5 | -54.9 | 42.11 | 40.71 | |||||
Unlevered Free Cash Flow Margin | 56.54 | 57.02 | -49.42 | 48.66 | 50.89 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.16 | 0.16 | 0.16 | 0.15 | 0.16 | |||||
Fixed Assets Turnover | 0.18 | 0.18 | 0.19 | 0.2 | 0.21 | |||||
Receivables Turnover (Average Receivables) | 7.22 | 7.15 | 1.57 | 0.86 | 0.9 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.41 | 0.93 | 10.29 | 9.63 | 8.73 | |||||
Quick Ratio | 1.41 | 0.93 | 10.29 | 9.63 | 8.73 | |||||
Operating Cash Flow to Current Liabilities | 3.59 | 2.51 | 4.21 | 3.85 | 3.31 | |||||
Days Sales Outstanding (Average Receivables) | 50.56 | 51.21 | 232.82 | 426.7 | 406.3 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 155.52 | 193.58 | 144.59 | 154.64 | 184.34 | |||||
Total Debt / Total Capital | 60.86 | 65.94 | 59.12 | 60.73 | 64.83 | |||||
LT Debt/Equity | 155.26 | 190.89 | 144.33 | 154.37 | 183.99 | |||||
Long-Term Debt / Total Capital | 60.76 | 65.02 | 59.01 | 60.62 | 64.71 | |||||
Total Liabilities / Total Assets | 62.82 | 67.81 | 60.68 | 62.29 | 66.31 | |||||
EBIT / Interest Expense | 2.62 | 3.35 | 3.48 | 2.96 | 1.92 | |||||
EBITDA / Interest Expense | 5.1 | 6.48 | 6.64 | 5.47 | 3.59 | |||||
(EBITDA - Capex) / Interest Expense | 5.1 | 6.48 | 6.64 | 5.47 | 3.59 | |||||
Total Debt / EBITDA | 5.26 | 5.74 | 5.82 | 6.02 | 6.09 | |||||
Net Debt / EBITDA | 5.15 | 5.64 | 5.44 | 5.68 | 5.84 | |||||
Total Debt / (EBITDA - Capex) | 5.26 | 5.74 | 5.82 | 6.02 | 6.09 | |||||
Net Debt / (EBITDA - Capex) | 5.15 | 5.64 | 5.44 | 5.68 | 5.84 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.25 | 0.96 | 7.87 | 6.78 | 5.41 | |||||
Gross Profit, 1 Yr. Growth % | 1.09 | 0.79 | 7.95 | 6.3 | 5.47 | |||||
EBITDA, 1 Yr. Growth % | -0.79 | -0.21 | 9.13 | 0.54 | 3.22 | |||||
EBITA, 1 Yr. Growth % | -5.53 | -0.68 | 8.68 | 2.34 | 1.46 | |||||
EBIT, 1 Yr. Growth % | -4.61 | 0.6 | 10.65 | 3.9 | 2.19 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -21.62 | 2.55 | 461.35 | -80.67 | -27.02 | |||||
Net Income, 1 Yr. Growth % | -21.62 | 2.55 | 461.35 | -80.67 | -27.02 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -21.59 | 2.17 | 461.7 | -80.68 | -27.45 | |||||
Normalized Net Income, 1 Yr. Growth % | -9.98 | 14.31 | 12.37 | -3.43 | -25.92 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.85 | 2.55 | -0.68 | 2.45 | -1.28 | |||||
Accounts Receivable, 1 Yr. Growth % | 3.87 | 0.94 | 780.02 | 3.45 | 0.19 | |||||
Total Assets, 1 Yr. Growth % | 1.04 | 1.07 | 21.14 | 1.52 | -1.84 | |||||
Common Equity, 1 Yr. Growth % | -8.5 | -12.51 | 48 | -2.65 | -12.29 | |||||
Tangible Book Value, 1 Yr. Growth % | -7.74 | -11.91 | 53.03 | -2.53 | -12.67 | |||||
Cash From Operations, 1 Yr. Growth % | -0.64 | 3.65 | 7.95 | -1.93 | -8.26 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 8.23 | 6.09 | -205.26 | -181.91 | 1.9 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 7.83 | 1.82 | -186.28 | -205.13 | 10.24 | |||||
Dividend Per Share, 1 Yr. Growth % | 1.49 | 1.47 | 1.45 | 1.43 | 1.41 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.77 | 1.11 | 4.35 | 7.32 | 6.09 | |||||
Gross Profit, 2 Yr. CAGR % | 2.71 | 0.94 | 4.3 | 7.12 | 5.88 | |||||
EBITDA, 2 Yr. CAGR % | 1.61 | -0.13 | 4.36 | 4.75 | 1.87 | |||||
EBITA, 2 Yr. CAGR % | -0.78 | -2.53 | 3.89 | 5.46 | 1.9 | |||||
EBIT, 2 Yr. CAGR % | 2.04 | -1.35 | 5.5 | 7.22 | 3.04 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -35.52 | -10.35 | 139.93 | 4.17 | -62.44 | |||||
Net Income, 2 Yr. CAGR % | -35.52 | -10.35 | 139.93 | 4.17 | -62.44 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -35.8 | -10.49 | 139.56 | 4.17 | -62.56 | |||||
Normalized Net Income, 2 Yr. CAGR % | 1.88 | 2.53 | 13.33 | 4.17 | -15.42 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -0.56 | 1.7 | 0.92 | 0.87 | 0.57 | |||||
Accounts Receivable, 2 Yr. CAGR % | 7.93 | 2.4 | 198.05 | 201.72 | 1.81 | |||||
Total Assets, 2 Yr. CAGR % | -0.12 | 1.05 | 10.65 | 10.9 | -0.17 | |||||
Common Equity, 2 Yr. CAGR % | -7.1 | -10.52 | 13.79 | 20.04 | -7.6 | |||||
Tangible Book Value, 2 Yr. CAGR % | -6.2 | -9.85 | 16.1 | 22.13 | -7.74 | |||||
Cash From Operations, 2 Yr. CAGR % | -3.71 | 1.48 | 5.78 | 2.89 | -5.15 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 4.81 | 7.44 | 10.45 | -7.15 | -8.64 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 4.43 | 5.1 | -2.43 | -4.76 | 7.66 | |||||
Dividend Per Share, 2 Yr. CAGR % | 1.5 | 1.48 | 1.46 | 1.44 | 1.42 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.35 | 2.16 | 3.31 | 5.16 | 6.68 | |||||
Gross Profit, 3 Yr. CAGR % |